SUBSTITUTED-ARYL-2-PHENYLETHYL-1H-IMIDAZOLE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA 2B AND/OR ALPHA 2C ADRENERGIC RECEPTORS
申请人:Sinha Santosh C.
公开号:US20090176843A1
公开(公告)日:2009-07-09
A compound having selective modulating activity at the alpha 2B and/or alpha 2C adrenergic receptor subtypes is represented by the general Formula 1:
wherein
n=1-4;
X is C or N;
R
1
—R
6
can be the same or different and are independently selected from the group consisting of H, C
1-6
alkyl, OCH
3
, OH, F, Cl, Br, CH
2
OH, CH
2
N(R
7
)
2
, C(O)R
8
, CH
2
CN, CF
3;
wherein R
7
is H or C
1-6
alkyl; and
R
8
is C
1-6
alkyl or aryl.
The compounds of Formula 1 can be incorporated in pharmaceutical compositions and used in methods of treatment of alpha 2 receptor mediated diseases and conditions.
具有选择性调节α2B和/或α2C肾上腺素受体亚型活性的化合物由通式1表示:其中n=1-4;X为C或N;R1—R6可以相同也可以不同,并且独立地选自H、C1-6烷基、OCH3、OH、F、Cl、Br、CH2OH、CH2N(R7)2、C(O)R8、CH2CN、CF3的群;其中R7为H或C1-6烷基;R8为C1-6烷基或芳基。通式1的化合物可以被纳入药物组成中,并用于治疗α2受体介导的疾病和病况的方法。